Join
Contact

SMFM’s High-Risk Pregnancy Week is more than an awareness campaign—it’s a movement to transform the conversation around high-risk pregnancy care. By educating the public, influencing policy, and strengthening the visibility of MFM specialists, this initiative drives meaningful change for maternal and fetal health. Our goals include:

EXPANDING EDUCATIONAL OPPORTUNITIES FOR HEALTHCARE PROFESSIONALS
through webinars and clinical education.

ENCOURAGE PATIENTS AND THE GENERAL PUBLIC
to discuss with their healthcare providers, including resources to identify and understand what a high-risk pregnancy is, and how to navigate your high-risk pregnancy with your provider.

ENGAGING WITH LEGISLATORS AND POLICYMAKERS
to highlight policies that ensure all families have access to specialized maternal care through advocacy and policy initiatives.

What MFM Specialists Treat

Complex conditions, expert care.
Maternal-fetal medicine specialists manage a wide range of conditions that require advanced expertise.
Preeclampsia and Hypertension Monitoring and managing blood pressure complications that affect both mother and baby. Preterm Birth Risk
Identifying and managing risk factors for early delivery, including cerclage and progesterone therapy.		 Multiple Pregnancies
Specialized management for twins, triplets, and higher-order multiples and their unique risks.
Fetal Anomalies
Advanced ultrasound and fetal echo to diagnose and plan care for structural differences.		 Placenta Complications
Diagnosing and managing placenta previa, accreta, and other placental conditions.		 Chronic Conditions
Managing diabetes, autoimmune disorders, heart disease, and other conditions in pregnancy.

Find what you need
Whether you're a patient, provider, or advocate, we have resources for you.
Why It Matters

High-risk pregnancies are more common than you think. 

Maternal-fetal medicine specialists provide expert care for the millions of families navigating complex pregnancies every year.

Become a Partner

Join SMFM in increasing awareness and transforming the conversation around high-risk pregnancy care.

Sign on as an ambassador and help educate colleagues, patients, and other professionals. Ambassadors receive complimentary access to educational webinars and resources featured during the week.

Sign on as a Partner

For Patients and Families 
Understand your care		 For Clinicians
Clinical tools and education

For Advocates
Join us in the work
What to expect at your first MFM visit - Coming soon Consults and guidelines Take action with the Sate Liaison Network
Patient fact sheets by condition Evidence-based learning by MFM experts Tools to Support Your Advocacy
Find an MFM specialist near you The latest research Topic Deep Dives
Patient support groups Patient safety and quality resources Policies and Positions

SMFM Advocacy in Action
SMFM advocates in Washington, DC, and in states across the country to advance optimal and equitable perinatal and reproductive health. Learn about our efforts and join us in the work.  



Virtual Partner Briefing: Assessing and Using Maternal Mortality Data 
Monday, June 1 from 3:00–4:00 PM ET		 Virtual Briefing: Drug Development in Pregnancy 
Friday, June 5 starting at 10:00 AM ET

Collecting and examining maternal mortality data is crucial to understanding the drivers of mortality, developing data-driven policy and interventions, improving health equity, and preventing future tragedies. However, the most common US data sources vary in the information they collect, which can create challenges when assessing and using the data.
 
During this briefing, SMFM staff will discuss the different types of maternal mortality data in the US and the most common data sources, as well as important considerations when using and referencing data in your work and when advocating for maternal health policy and programs. Staff will also incorporate brief data updates on the latest data from the Pregnancy Monitoring Surveillance System (PMSS) and the Maternal Mortality Review Information App (MMRIA).

Note: This briefing is open to SMFM members and partners. 

Register for the Briefing
Nearly 90% of pregnant women use at least one medication during pregnancy, yet most drug labels lack pregnancy-specific safety or efficacy data, leaving clinicians and patients to make critical decisions without robust evidence. This briefing will examine the gaps driving this problem, highlight federal initiatives addressing them, and discuss bipartisan legislative solutions to improve data generation and ensure that pregnant and lactating patients have access to safe, effective treatments.
Note: This briefing is open to SMFM members, partners, and the public.



Early Awareness Can Change Outcomes. Spread the Word
Download free resources to help increase awareness, transform the conversation, and ensure optimal and equitable access for all people who desire or experience pregnancy.
What to Expect When You're Referred to an MFM Subspecialist 
    Digital Toolkit
Download, Print, and Share.
This patient focused infographic provides an overview on what to expect when referred to an MFM subspecialist and addresses conditions that commonly lead to a referral from an OB-GYN, what patients can expect, and questions to ask your doctor. Download, print, and share this resource with your patients.
Download and Spread the Word
Download our free graphics with suggested messages to share across social media.